ARCHIVES

FDA Roundup: Public Citizen Uses Logic of FDA’s Critical Path to Challenge Decision On Anti-Obesity Drug.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

June 22, 2012

Construction Money In Budget Earmarked For Frederick

February 9, 1990

Southern Screening Contract Now at $2 Mil. Year For Five Year

June 7, 1974

Cancer Advocacy: Survivors, Supporters Gather to Light Candles, Curse the Darkness

October 1, 1999

Commemoration Planned For Heidelberger

February 11, 1983

Carcinogenesis Testing To Stay In NCI, But Control Will Go To New Group Headed By Rall

September 15, 1978